A Multifaceted Intervention on Reducing Immunization Errors
Launched by HOSPITAL ISRAELITA ALBERT EINSTEIN · Dec 17, 2024
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to find ways to reduce mistakes that can happen during vaccinations, which is important for keeping people safe and healthy. The study will look at a special program used in vaccination rooms in Brazil to see if it helps lower the number of errors when giving vaccines. Researchers will also track any negative reactions that might happen after people receive their vaccines and look for patterns or reasons behind them.
To participate in this trial, health care units need to be giving at least 2,000 vaccine doses each month. However, units that do not provide consistent vaccination services are not eligible. While the trial is not recruiting participants yet, it aims to gather important information that could help improve vaccination practices and ensure safer immunizations for everyone.
Gender
ALL
Eligibility criteria
- • Cluster Inclusion Criteria
- • Health units with vaccination rooms administering at least 2,000 doses of vaccines/immunobiologicals per month,
- • Cluster Exclusion Criteria
- • Primary health units that do not provide consistent vaccination services to the population.
About Hospital Israelita Albert Einstein
Hospital Israelita Albert Einstein is a leading healthcare institution in Brazil, renowned for its commitment to excellence in patient care, education, and research. As a prominent clinical trial sponsor, the hospital emphasizes innovation and scientific advancement, facilitating cutting-edge studies across various medical disciplines. With a state-of-the-art infrastructure and a dedicated team of professionals, Hospital Israelita Albert Einstein fosters collaboration with global research networks to enhance clinical outcomes and contribute to the advancement of medical knowledge. The institution is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sao Paulo, , Brazil
Patients applied
Trial Officials
Henrique A Fonseca, ScD, PhD
Study Chair
Hospital Albert Einstein
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported